BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19944754)

  • 1. Sequence-function correlation of aromatase and its interaction with reductase.
    Hong Y; Li H; Yuan YC; Chen S
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):203-6. PubMed ID: 19944754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of aromatase.
    Hong Y; Li H; Yuan YC; Chen S
    Ann N Y Acad Sci; 2009 Feb; 1155():112-20. PubMed ID: 19250198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector role of cytochrome P450 reductase for androstenedione binding to human aromatase.
    Zhang C; Catucci G; Di Nardo G; Gilardi G
    Int J Biol Macromol; 2020 Dec; 164():510-517. PubMed ID: 32698066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human placental estrogen synthetase (aromatase). Effect of environment on the kinetics of protein-protein and substrate-protein interactions and the production of 19-oxygenated androgen intermediates in the purified reconstituted cytochrome P450 enzyme system.
    Sethumadhavan K; Bellino FL
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):381-94. PubMed ID: 1911429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the complex formation, interaction and electron transfer pathway between the "open" conformation of NADPH-cytochrome P450 reductase and aromatase.
    Dai Y; Zhen J; Zhang X; Zhong Y; Liu S; Sun Z; Guo Y; Wu Q
    Steroids; 2015 Sep; 101():116-24. PubMed ID: 26087061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Structural Evolution of Cytochrome P450 Aromatase.
    Di Nardo G; Zhang C; Marcelli AG; Gilardi G
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for androgen specificity and oestrogen synthesis in human aromatase.
    Ghosh D; Griswold J; Erman M; Pangborn W
    Nature; 2009 Jan; 457(7226):219-23. PubMed ID: 19129847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding features of steroidal and nonsteroidal inhibitors.
    Hong Y; Rashid R; Chen S
    Steroids; 2011 Jul; 76(8):802-6. PubMed ID: 21420422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine gonadal and placental isozymes of aromatase cytochrome P450: sub-cellular distribution and support by NADPH-cytochrome P450 reductase.
    Corbin CJ; Trant JM; Conley AJ
    Mol Cell Endocrinol; 2001 Feb; 172(1-2):115-24. PubMed ID: 11165045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC; Watson DM; So OY
    Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-Atom Simulations Disclose How Cytochrome Reductase Reshapes the Substrate Access/Egress Routes of Its Partner CYP450s.
    Ritacco I; Saltalamacchia A; Spinello A; Ippoliti E; Magistrato A
    J Phys Chem Lett; 2020 Feb; 11(4):1189-1193. PubMed ID: 31986051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenodoxin supports reactions catalyzed by microsomal steroidogenic cytochrome P450s.
    Pechurskaya TA; Harnastai IN; Grabovec IP; Gilep AA; Usanov SA
    Biochem Biophys Res Commun; 2007 Feb; 353(3):598-604. PubMed ID: 17188650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of aromatase (CYP19) metabolite ratios to characterize electron transfer from NADPH-cytochrome P450 reductase.
    Grogan J; Shou M; Zhou D; Chen S; Korzekwa KR
    Biochemistry; 1993 Nov; 32(45):12007-12. PubMed ID: 8218277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-dimensional model of aromatase cytochrome P450.
    Graham-Lorence S; Amarneh B; White RE; Peterson JA; Simpson ER
    Protein Sci; 1995 Jun; 4(6):1065-80. PubMed ID: 7549871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organization of cytochrome P450 enzymes involved in sex steroid synthesis: PROTEIN-PROTEIN INTERACTIONS IN LIPID MEMBRANES.
    Praporski S; Ng SM; Nguyen AD; Corbin CJ; Mechler A; Zheng J; Conley AJ; Martin LL
    J Biol Chem; 2009 Nov; 284(48):33224-32. PubMed ID: 19805543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-dimensional model of CYP19 aromatase for structure-based drug design.
    Karkola S; Höltje HD; Wähälä K
    J Steroid Biochem Mol Biol; 2007; 105(1-5):63-70. PubMed ID: 17583493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray structure of human aromatase reveals an androgen-specific active site.
    Ghosh D; Griswold J; Erman M; Pangborn W
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):197-202. PubMed ID: 19808095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of human placental aromatase cytochrome P-450.
    Kellis JT; Vickery LE
    J Biol Chem; 1987 Mar; 262(9):4413-20. PubMed ID: 3104339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of equine testicular cytochrome P-450 aromatase: comparison with the human enzyme.
    Moslemi S; Vibet A; Papadopoulos V; Camoin L; Silberzahn P; Gaillard JL
    Comp Biochem Physiol B Biochem Mol Biol; 1997 Sep; 118(1):217-27. PubMed ID: 9418012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of diabetes on placental aromatase activity.
    McRobie DJ; Korzekwa KR; Glover DD; Tracy TS
    J Steroid Biochem Mol Biol; 1997; 63(1-3):147-53. PubMed ID: 9449216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.